2017 Napa Pain Conference Addendum to the Syllabus
SpectrumCare is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
SpectrumCare designates this live activity for a maximum of 19.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following information has been revised, or corrected from what was printed in the on-site syllabus and/or evaluation
Updated Disclosure Information
Those involved in the CME portion of the program disclosed the following relationships:
New – Mark Schumacher, MD
New – No financial relationships to disclose
Gregory Scherrer, PhD, PharmD
Updated – Consultant: Epiodyne
(pre-clinical, not intended for human application)
Linda Watkins, PhD
Consultant: Xalud Therapeutics (pre-clinical)
Updated – Stock: Xalud Therapeutics (pre-clinical)
CME Credit corrections
AMA PRA Category 1 Credits™ for this live activity have been corrected to a maximum of 19.50, instead of the previously published 19.75.